Startseite Pregnancy with uncorrected tetralogy of Fallot (TOF), pulmonary atresia and major aorto-pulmonary collateral arteries (MAPCA)
Artikel Öffentlich zugänglich

Pregnancy with uncorrected tetralogy of Fallot (TOF), pulmonary atresia and major aorto-pulmonary collateral arteries (MAPCA)

  • Luis M. Gomez EMAIL logo , Ryan C. Jones , Maria R. Fuertes , Danielle L. Tate und Jaya Ramanathan
Veröffentlicht/Copyright: 12. März 2018

Abstract

Pregnancy with uncorrected tetralogy of Fallot (TOF) is a rare event, and increases the risk for fetal growth restriction and adverse outcomes related to worsening right-to-left shunt, cyanosis, pulmonary hypertension and arrhythmia. Obstetric management is made on a case-by-case basis. Patients who remain stable can achieve term pregnancies and the mode of delivery can be based on obstetric indications. We present the case of a 21-year-old primigravida with baseline cyanosis, oxygen saturation 90% at rest (74% with activities), hematocrit 50%, and echocardiogram showing pulmonary atresia, ventricular septal defect (VSD), and major aorto-pulmonary collateral arteries (MAPCA). We managed her with aspirin, metoprolol and oxygen supplementation. She delivered at 38 weeks (fetal growth restriction) via cesarean; she received epidural and endocarditis prophylaxis. Three years later, she presented pregnant and had a repeat cesarean at term. Both newborns had normal structural hearts. Knowledge of the cardiovascular physiology during pregnancy and baseline assessment, and a multidisciplinary management are key aspects in the management of these cases during pregnancy.

Introduction

Uncorrected tetralogy of Fallot (TOF) is extremely rare; affected individuals usually undergo repair early in life. Pregnancy in affected women is associated with fetal loss, fetal growth restriction (FGR), congenital heart defects (CHDs), and maternal morbidity and mortality related to worsening right-to-left shunt, cyanosis, pulmonary artery hypertension (PAH), arrhythmia and thrombosis [1]. TOF typically presents with pulmonary stenosis, ventricular septal defect (VSD), overriding aorta (OAo) and right ventricular hypertrophy (RVH). A variant form presents with pulmonary atresia (instead of pulmonary stenosis); here, the blood supply to the lungs is provided by major aorto-pulmonary collateral arteries (MAPCA) [2].

Due to the sparsity of reported cases, the management of affected patients is done on a case-by-case basis. We present a patient with uncorrected TOF and MAPCA who achieved two successful term pregnancies and provide management recommendations.

Case report

A 21-year-old primigravida presented to our clinic at 6 weeks with cyanosis and a continuous cardiac murmur. She reported fatigue with strenuous activities. Her heart rate (HR) was 90 beats/min, oxygen saturation (SpO2) 90% at rest (74% during ambulation) and body mass index 16 kg/m2; hematocrit was 50.4%. An echocardiogram showed a large VSD, balanced biventricular chamber size, RVH, pulmonary atresia and OAo (Figure 1). MAPCA were seen from the descending aorta supplying both lungs (Figure 2). Upon diagnosis of TOF, cardiothoracic surgery considered the patient at significant risk for repair. After discussing maternal (worsening cardiac function, hypoxia, arrhythmia, death) and fetal risks (CHD, FGR and perinatal death), she declined termination. Maternal chromosomal analyses were normal.

Figure 1: 
Maternal echocardiogram showing infundibular ventricular septal defect (VSD) and overriding aorta (OAo).
Figure 1:

Maternal echocardiogram showing infundibular ventricular septal defect (VSD) and overriding aorta (OAo).

Figure 2: 
Maternal echocardiogram showing right pulmonary atresia (RPA), aorta (Ao) and major aorto-pulmonary collateral arteries (MAPCA).
Figure 2:

Maternal echocardiogram showing right pulmonary atresia (RPA), aorta (Ao) and major aorto-pulmonary collateral arteries (MAPCA).

We started acetylsalicylic-acid (ASA) 81 mg due to polycythemia, and recommended heparin thromboprophylaxis (which she declined), metoprolol (for non-sustained ventricular tachycardia), oxygen supplementation and frequent hydration. Repeat echocardiograms reported stable findings with balanced biventricular chamber size, right-to-left shunt and no reported PAH. Of note, the patient did not have angiogram or magnetic resonance imaging (MRI).

The fetal echocardiogram was normal. We started growth scans and non-stress tests (NSTs) at 28 weeks. At 32 weeks, we diagnosed FGR and recommended antenatal corticosteroids and Doppler studies. At 38 weeks, we recommended delivery due to suboptimal fetal growth.

Upon admission for delivery, the HR was 76 beats/min, SpO2 86% at rest, and hematocrit 43%. We used intravenous lines with air-filters. We inserted an arterial line to monitor fluid shifts. Epidural was placed (bupivacaine and fentanyl infusion) before starting oxytocin. The cervix was dilated to 3 cm; simultaneously she became tachycardic, hypotensive, with fetal heart rate (FHR) decelerations. Although the FHR improved with maternal resuscitation, her symptoms recurred at repeat vaginal exams; therefore, we opted for cesarean. She received bacterial endocarditis prophylaxis (ampicillin). After delivery, we repaired the uterus without exteriorization. Phenylephrine was administered to maintain the systolic blood pressure (BP) above 100 mm Hg. We used methylergonovine for uterine atony. Apgar score was 9 (1 and 5 min) and birthweight 2300 g confirming FGR.

Post-operatively, we ordered telemetry and heparin thromboprophylaxis. Three days later, she was discharged with ASA and metoprolol. She declined contraception.

Three years later, she presented pregnant at 15 weeks. We continued ASA and metoprolol. Baseline echocardiogram was unchanged. The fetal echocardiogram was normal. At 31 weeks, we diagnosed FGR. We performed a cesarean at 37 weeks with permanent sterilization. We used a non-invasive monitor, Aesculon (Osypka Medical, Inc.; La Jolla, CA, USA) to assess BP, HR, systemic vascular resistance (SVR), cardiac output (CO) and SpO2 during cesarean (Table 1). CO, SVR and BP decreased after epidural which stabilized after intravenous phenylephrine. SVR and BP again decreased after placental removal and after oxytocin infusion (reversed with phenylephrine). During these episodes, SpO2 remained stable suggesting no worsening in the right-to-left shunting.

Table 1:

Aesculon non-invasive monitor hemodynamic data during cesarean section.

SBP (mm Hg) DBP (mm Hg) HR (beats/min) CO (L/min) SV (mL/beat) SVR (dynes-sec /cm−5) SpO2
Baseline 114 62 86 4.71 72.7 1393 83%
Epidural T4 level 98 60 78 3.83 66.2 1166 86%
Phenylephrinea 118 64 59 4.17 71.2 1407 85%
Placental delivery 103 61 68 4.4 67 1251 86%
Oxytocin 98 56 74 5.3 76 1036 85%
Phenylephrineb 118 64 67 4.2 70 1374 86%
  1. SBP = Systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, CO = cardiac output, SV = stroke volume, SVR = systemic vascular resistance, SpO2 = oxygen saturation.

  2. aAfter epidural placement before delivery.

  3. bAfter delivery of the placenta.

One year later, our patient remains stable; her two daughters are healthy and without CHD.

Discussion and review

Our patient presented with a variant form of TOF VSD-pulmonary atresia along with the presence of MAPCA. Her baseline and follow up echocardiograms did not report the presence of PAH; however, we cannot exclude that there is no PAH in certain areas of the lung as our patient did not have angiogram or MRI. Because her baseline SpO2 was 90% on room air we assume that she did not have PAH. Maternal karyotype is recommended because the rate of associated aneuploidy or 22q11 deletion is 20–30%; [3] our patient had normal chromosomal analyses.

Publications on pregnancy management in uncorrected TOF and women with cyanosis are scant [4]. Pregnancy is discouraged until the defect is repaired, and in those with unplanned pregnancy the counseling should involve termination [4]. Our patient decided to continue with the pregnancy and we co-managed her with cardiology and anesthesiology; we highlight some aspects of her management:

  • Serial echocardiograms, antenatal testing and growth scans are warranted.

  • Physiologic decrease in SVR, increase in pulmonary vascular resistance (PVR), and/or increase in HR induce/worsen right-to-left shunting leading to more pronounced hypoxemia, cyanosis and increased risk for maternal and fetal death [4], [5], [6], [7].

  • We prevented tachycardia with metoprolol, adequate hydration, pain control (epidural) and minimizing blood loss during delivery.

  • We minimized hypotension by monitoring strict fluid shifts and blood loss with an arterial line.

  • Hypotension can be prevented by using methylergonovine instead of oxytocin; of note, our patient became hemodynamically unstable with oxytocin use.

  • Cyanosis leads to tissue hypoxia, poor placental oxygen transfer, FGR and even fetal demise [5], [8]. Although betablockers have been linked to FGR, in this case FGR was an effect of cyanosis. Supplemental oxygen may ameliorate these risks and partially improve oxygen delivery to the placenta [4].

  • Polycythemia is associated with hyperviscosity and thrombosis. The utility of anticoagulants in polycythemia without prior thrombosis is questionable [5]. Nonetheless, prophylactic anticoagulation should be considered for women who remain in bed rest [4]. We used ASA throughout the pregnancy and reserved heparin to the post-operative course.

  • Epidural anesthesia with slow and controlled incremental doses is safe to use in women with uncorrected TOF [9] and is preferred to spinal or general anesthesia to avoid profound sympathetic block, hypotension, rapid decrease in SVR reduction or tachycardia which induce/worsen right-to-left shunt [4].

  • Phenylephrine is preferred to ephedrine as a vasopressor because it does not induce tachycardia, has minimal impact in the CO, maintains the SVR at normal-to-high range, and allows a stable SpO2 preventing worsening of right-to-left shunting (Table 1).

  • Non-invasive monitoring provides useful hemodynamic information at baseline, during epidural, labor, placental delivery and oxytocin infusion (Table 1).

  • The rate of CHD in women with TOF is 5% [10]. Fetal echocardiograms were normal, and neonatal sonograms confirmed no CHD.

  • Hematocrit >65% has been associated with stillbirth; [5], [11] our patient never reached that hematocrit concentration.

  • There are no standard recommendations on the time or mode of delivery, but vaginal route with adequate pain relief (epidural) is preferred [4]. Because of stable maternal status and reactive NST, our patient was delivered at term. Because she became hemodynamically unstable during labor, we opted for cesarean.

  • Patients with uncorrected TOF must receive endocarditis antibiotic prophylaxis before delivery [12].

  • During cesarean avoid unnecessary fundal pressure to minimize inferior vena cava compression, and preferably repair the uterus without exteriorization to minimize the risk of a vagal reaction or venous air embolism [4], [13].

  • Methylergonovine is preferred to control the uterine tone over oxytocin which decreases the SVR significantly (Table 1).

  • Filtered intravenous lines must be used to avoid paradoxical air embolism [7].

Finally, this case underlines the importance of a multidisciplinary approach with a team composed of a maternal-fetal medicine obstetrician, cardiologist and anesthesiologist familiar with the physiologic cardiovascular changes during pregnancy.

Author’s Statement

  1. Conflict of interest: Authors state no conflict of interest.

Material and Methods

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.

  3. Financial Disclosure: The authors have no connection to any companies or products mentioned in this article.

References

[1] Veldtman GR, Connolly HM, Grogan M, Ammash NM, Warnes CA. Outcomes of pregnancy in women with tetralogy of fallot. J Am Coll Cardiol. 2004;44;174–80.10.1016/j.jacc.2003.11.067Suche in Google Scholar PubMed

[2] Grant EK, Berger JT. Use of pulmonary hypertension medications in patients with tetralogy of Fallot with pulmonary atresia and multiple aortopulmonary collaterals. Pediatr Cardiol. 2016;37:304–12.10.1007/s00246-015-1278-2Suche in Google Scholar PubMed

[3] Poon LC, Huggon IC, Zidere V, Allan LD. Tetralogy of Fallot in the fetus in the current era. Ultrasound Obstet Gynecol. 2007;29:625–7.10.1002/uog.3971Suche in Google Scholar PubMed

[4] Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135:e50–87.10.1161/CIR.0000000000000458Suche in Google Scholar PubMed

[5] Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89:2673–6.10.1161/01.CIR.89.6.2673Suche in Google Scholar

[6] Hameed AB, Chan K, Ghamsary M, Elkayam U. Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum. Clin Cardiol. 2009;32:E60–2.10.1002/clc.20391Suche in Google Scholar PubMed PubMed Central

[7] Koos B. Management of uncorrected, palliated, and repaired cyanotic congenital heart disease in pregnancy. Prog Pediatr Cardiol. 2004;19:25–45.10.1016/j.ppedcard.2003.09.004Suche in Google Scholar

[8] Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation. 2006;113:517–24.10.1161/CIRCULATIONAHA.105.589655Suche in Google Scholar PubMed

[9] Adinarayanan S, Parida S, Kavitha J, Balachander H. Spinal anesthetic for emergency cesarean section in a parturient with uncorrected tetralogy of Fallot, presenting with abruptio placentae and gestational hypertension. J Anaesthesiol Clin Pharmacol. 2014;30:400–2.10.4103/0970-9185.137276Suche in Google Scholar PubMed PubMed Central

[10] Kampman MA, Siegmund AS, Bilardo CM, van Veldhuisen DJ, Balci A, Oudjik MA, et al. Uteroplacental Doppler flow and pregnancy outcome in women with tetralogy of Fallot. Ultrasound Obstet Gynecol. 2017;49:231–9.10.1002/uog.15938Suche in Google Scholar PubMed

[11] Juwarkar C, Bharne SS. Anesthetic management of a parturient with uncorrected tetralogy of Fallot for Cesarean section. Anesth Essays Res. 2012;6:244–6.10.4103/0259-1162.108358Suche in Google Scholar PubMed PubMed Central

[12] Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. The Council on Scientific Affairs of the American Dental Association has approved the guideline as it relates to dentistry. In addition, this guideline has been endorsed by the American Academy of Pediatrics, Infectious Diseases Society of America, the International Society of Chemotherapy for Infection and Cancer, and the Pediatric Infectious Diseases Society. Circulation. 2007;116:1736–54.10.1161/CIRCULATIONAHA.106.183095Suche in Google Scholar PubMed

[13] Edie-Osagie EC, Hopkins RE, Ogbo V, Lockhat-Clegg F, Ayeko M, Mayers FN. Uterine exteriorisation at caesarean section: influence on maternal morbidity. Br J Obstet Gynaecol. 1998;105:1070–8.10.1097/00006254-199905000-00008Suche in Google Scholar

Received: 2017-09-30
Accepted: 2018-02-13
Published Online: 2018-03-12

©2018 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Case Reports – Obstetrics
  2. Total abnormal invasive placenta in a woman with a history of placental abruption and severe hemorrhage
  3. Use of eculizumab in pregnancy-associated atypical hemolytic uremic syndrome
  4. Comparison between leukocyte esterase activity and histopathological examination in identifying chorioamnionitis
  5. Uneventful delivery of two pregnancies in a woman with severe factor XII deficiency: case report and systematic review
  6. Littoral cell angioma with splenic rupture in pregnancy
  7. A rare form of congenital high airway obstruction syndrome and a literature review of ex utero intrapartum treatment
  8. Self deinfibulation during unassisted home delivery: a hitherto unknown dimension of female genital mutilation?
  9. Uterine rupture of a non-communicating rudimentary horn pregnancy with resultant successful outcome of an extremely premature baby born at 24 weeks of gestation
  10. Pregnancy with uncorrected tetralogy of Fallot (TOF), pulmonary atresia and major aorto-pulmonary collateral arteries (MAPCA)
  11. Coronary artery vasospasm induced acute myocardial infarction in pregnancy: a new case and systematic review of the literature
  12. Case Reports – Fetus
  13. Metaphyseal corner fracture caused in utero by external cephalic version – a rare presentation
  14. Isolated unilateral severe fetal hydrothorax: spontaneous resolution after birth
  15. Case Reports – Newborn
  16. Clinical study of a patient with congenital myotonic dystrophy reveals chylothorax as neonatal presentation of the disease
  17. A case of significant subcutaneous emphysema on non-invasive respiratory support in a late preterm infant
  18. Multiple brain abscesses caused by Serratia marcescens in preterm newborn
  19. Prenatal diagnosis of rapidly involuting congenital hemangioma: a case report and review of the literature
  20. Congenital diaphragmatic hernia and double-outlet right ventricle: elements of trisomy 18?
  21. Anti-D-induced severe hemolytic disease of the newborn in an Omani newborn born a rhesus-positive mother
  22. Congenital intrahepatic portosystemic shunts: a potential cause for early-onset neonatal cholestasis
  23. Diffuse pulmonary interstitial emphysema in a late preterm neonate without mechanical ventilation
Heruntergeladen am 30.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/crpm-2017-0053/html
Button zum nach oben scrollen